Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Blood pressure lowering and potassium intake

In this issue Chaudhary et al., accessed the Dietary Approaches to Stop Hypertension Sodium Trial (DASH-Sodium) dataset via the NHLBI and BioLINCC to obtain data on systolic blood pressure (SBP) from individuals deemed to be salt sensitive (SS) or salt resistant (SR) based on the response to changes in Na+ intake [1]. Importantly, Na+ intake in the trial ranged from 1.5 to 3.3 g/day over a 30-day period and participants were also encouraged to increase K+ intake [2]. The authors examined the relationship between SBP and urinary Na+ and K+ excretion, and the Na+/K+ ratio via linear regression. Consistent with previous literature, there was a significant drop in SBP in both the SS and SR participants assigned to the DASH-low sodium diet as compared to baseline screening values. However, the authors indicated they found no association between urinary K+ excretion or the urinary Na+/K+ ratio and change in SBP in either the SS or SR groups. This lack of association occurred even though urinary K+ excretion increased from 2.2 to 3.2 and 2.1 to 3.2 gm/d on the DASH-low sodium diet when compared to pre-screening levels suggestive of an increase in dietary consumption of K+. Furthermore, the urine Na+/K+ ratio decreased from 1.9 to 0.6 and 1.8 to 0.5 in the SR and SS groups respectively. The authors concluded that despite the perceived increase in K+ consumption and reduction in Na+ consumption, the Na+/K+ ratio bore no relationship to SBP.

Potassium (K+) is an extremely important mineral, as supported by National Academy of Science, Engineering, and Medicine Dietary Reference Intakes (DRI), and has been designated as a “nutrient of public health concern” due to its general under consumption [3]. In 2004, the Food and Nutrition Board of the Institute of Medicine established recommended intake levels of 4700 mg/day of K+ [4]. Despite these recommendations, data from National Health and Nutrition Examination Survey (NHANES) 2007–2008 estimated mean intakes in the United States to be 2290 mg/day for women and 3026 mg/day for men, substantially lower than the suggested values [5]. This relative “deficiency” is even more noteworthy when one considers the K+ intake of prehistoric man was estimated to be 15,000 mg/day, which actually exceeds the NHANES recommendations by a factor greater than 4 [6]. Despite studies demonstrating blood pressure lowering effects of increasing K+ intake, the 2019 DRI concluded more evidence is required to support a DRI for K+ [7].

The daily intake of Na+ in Western industrialized societies is about three times higher than the daily intake of K+ on a molar basis [7]. Urinary excretion of K+ and Na+ are the most accurate measure of dietary consumption [8]. Data suggest the urinary Na+/K+ ratio has a stronger association with blood pressure than Na+ or K+ independently [9, 10]. A urinary Na+/K+ ratio <1 has been recommended as a beneficial target to improve long term blood pressure control [11, 12]. There are two ways of achieving this - either through dietary restriction of Na+ and/or through significant increases in dietary K+. While Chaudhary et al. conclude a urinary K+ excretion >1 g/day and a reduction in the urinary Na+/K+ ratio are not associated with lower SBP, the observation that SBP is increased when intake is <1 g K+/day suggests low dietary intake of K+ is associated with HIGHER blood pressure and supports the argument for increased dietary K+ intake. The findings of this study should be interpreted in the context of numerous other studies demonstrating increased K+ intake given as a supplement or achieved by a diet enriched in fruits and vegetable lowers BP in hypertensive and normotensive individuals [13,14,15].

Mechanistically, increased K+ intake leads to accumulation in the interstitium of the kidney causing an inhibitory effect on the thick ascending limb and to a lesser extent proximal tubular NaCl reabsorption resulting in increased flow and Na+ delivery to the distal nephron [16]. In addition, slight increases in plasma K+ concertation are sensed by cells in the initial portion of the distal convoluted tubule leading to an inhibitory effect on the thiazide sensitive Na+-Cl co-transporter (NCC). Increased flow and Na+ delivery to the aldosterone sensitive distal nephron (ASDN) stimulates electrogenic and flow mediated K+ secretion. In addition to maintaining a normal plasma K+ concentration, these natriuretic effects contribute to the blood pressure lowering effect of high K+ intake. By contrast, reductions in K+ intake lead to increased activity of NCC and limit K+ secretion by reducing Na+ delivery and flow to the ASDN. The effect of a K+ deficient diet to reduce K+ secretion at the expense of increased Na+ retention has been linked to the pathogenesis of salt-sensitive hypertension.

The blood pressure lowering effect of increased K+ intake is more pronounced in individuals with high salt intake. This effect is important since the population studied by Chaudhary were consuming a relatively low Na+ diet. In this setting, a small increase in dietary K+ intake, insufficient to cause a reduction in blood pressure, would cause a large decrease in the urinary Na+/K+ ratio. As a result, there would be no correlation between the ratio and blood pressure lowering. In this regard, the dietary intervention in the trial was to increase K+ intake to 4.7 gm/d and yet the majority of participants in the analysis had intakes in the range of 1–2 gm/d based on urinary K+ measurements. We believe current guidelines recommending increasing K+ intake for the prevention and treatment of hypertension are justified [17].

References

  1. Chaudhary P, Wainford R. Association of urinary sodium and potassium excretion with systolic blood pressure in the Dietary Approaches to Stop Hypertension Sodium Trial. 2020 (In Press).

  2. Sacks F, Svetkey L, Vollmer W, Appel L, Bray G, Harsha D, et al. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet. dash-sodium collaborative research group. N Engl J Med. 2001;344:3–10.

    CAS  Article  Google Scholar 

  3. DeSalvo K, Olson R, Casavale K. Dietary guidelines for Americans. J Am Med Assoc. 2016;315:457–8.

    CAS  Article  Google Scholar 

  4. Food and Nutrition Board, Institute of Medicine. Potassium. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, D.C.: National Academies Press; 2005. p. 186–268.

  5. USDA, Agricultural Research Service. 2010. Nutrient intakes from food. Mean amounts consumed per individual, by gender and age. What we eat in America, NHANES 2007–2008. Updated 14 April 2011. www.ars.usda.gov/ba/bhnrc/fsrg.

  6. Palmer BF, Clegg DJ. Achieving the benefits of a high potassium, Paleolithic diet, without the toxicity. Mayo Clin Proc. 2016;91:496–508.

    Article  Google Scholar 

  7. National Academies of Sciences E, Medicine, Health, Medicine D, Food, Nutrition B, et al. The National Academies Collection: Reports funded by National Institutes of Health. In: Oria M, Harrison M, Stallings VA, editors. Dietary reference intakes for sodium and potassium. Washington (DC): National Academies Press; 2019. https://doi.org/10.17226/25353.

  8. Palmer BF, Clegg DJ. The use of selected urine chemistries in the diagnosis of kidney disorders. Clin J Am Soc Nephrol. 2019;14:306–16.

    CAS  Article  Google Scholar 

  9. Tzoulaki I, Patel CJ, Okamura T, Chan Q, Brown IJ, Miura K, et al. A nutrient wide association study on blood pressure. Circulation. 2012;126:2456–64.

    CAS  Article  Google Scholar 

  10. Thi Minh Nguyen T, Miura K, Tanaka-Mizuno S, Tanaka T, Nakamura Y, Fujiyoshi A, et al. Association of blood pressure with estimates of 24-h urinary sodium and potassium excretion from repeated single-spot urine samples. Hypertens Res. 2019;42:411–8.

    Article  Google Scholar 

  11. Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M. INTERSALT study findings. Public health and medical care implications. Hypertension. 1989;14:570–7.

    CAS  Article  Google Scholar 

  12. Iwahori T, Miura K, Ueshima H, Tanaka-Mizuno S, Chan Q, Arima H, et al. Urinary sodium-to-potassium ratio and intake of sodium and potassium among men and women from multiethnic general populations: the INTERSALT study. Hypertens Res. 2019;42:1590–8.

    CAS  Article  Google Scholar 

  13. Mente A, O’Donnell M, Rangarajan S, McQueen M, Poirier P, Wielgosz A, et al. PURE investigators association of urinary sodium and potassium excretion with blood pressure. N. Engl J Med. 2014;371:601–11.

    Article  Google Scholar 

  14. Aburto N, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio F. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. Brit Med J. 2013;346:f1378.

    Article  Google Scholar 

  15. Whelton P, He J, Cutler J, Brancati F, Appel L, Follmann D, et al. Effects of oral potassium on blood pressure. meta-analysis of randomized controlled clinical trials. J Am Med Assoc. 1997;277:1624–32.

    CAS  Article  Google Scholar 

  16. Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis: core curriculum 2019. Am J Kidney Ds. 2019;74:682–95.

    CAS  Article  Google Scholar 

  17. Whelton P, Carey R, Aronow W, Casey D, Collins K, Dennison C, et al. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138:e484–594.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Biff F. Palmer.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Palmer, B.F., Clegg, D.J. Blood pressure lowering and potassium intake. J Hum Hypertens 34, 671–672 (2020). https://doi.org/10.1038/s41371-020-00396-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-020-00396-1

Search

Quick links